IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management III, LLC

Q1 2021 Holdings

Filed 2021-05-17 | 8 holdings | $49.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics, Inc.(ACRS)COM00461U105$49.3M1,954,90499.9%
Acceleron Pharma Inc.(XLRN)COM00434H108$14.7K108,6300.0%
Natera, Inc.(NTRA)COM632307104$12.9K127,3050.0%
FibroGen, Inc.(FGENEUR)COM31572Q808$10.6K305,7840.0%
Verona Pharma Plc.(VRNA)SPONSORED ADS925050106$9.3K1,111,1120.0%
Epizyme, Inc.(EPZMEUR)COM29428V104$8.7K998,2780.0%
Cymabay Therapeutics, Inc.(CBAYUSD)COM23257D103$7.5K1,641,8040.0%
Novavax, Inc.(NVAX)COM670002401$9075,0000.0%